APVOHealthcareNano-Cap

Aptevo Therapeutics Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Aptevo Therapeutics Inc. (APVO), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are APVO insiders buying or selling?

Aptevo Therapeutics Inc. insiders reported 24 open-market buys ($25.3M) and 2 sells ($16.9M) across 26 Form 4 filings — a net buying position of $8.5M.

Source: SEC EDGAR Form 4

Key Statistics (as of Nov 12, 2025)

Total Form 4 filings
26
SEC EDGAR
Insider filers
9
Insider buys (24)
$25.3M
Insider sells (2)
$16.9M

Insider sentiment

Net buying

Net insider flow of $8.5M in net buying.

Recent APVO insider transactions

DateInsiderRoleTypeSharesPriceValue
Nov 12, 2025Grady Grant IIIDirectorPurchase13.5K$1.49$20.1K
Jun 3, 2022John NiederhuberDirectorPurchase714$0.91$649.74
Nov 26, 2021Kevin C TangOtherSale921.3K$11.25$10.4M
Nov 22, 2021Kevin C Tang10% OwnerSale838.7K$7.75$6.5M
Nov 6, 2020TANG KEVIN C10% OwnerPurchase1.4M$17.30$24.8M
Aug 19, 2019Randy Joe MadduxSVP Operations, CMOPurchase25.0K$0.76$19.0K
Aug 14, 2019Fuad El-HibriDirectorPurchase100.0K$0.76$75.5K
Jul 30, 2019Fuad El-HibriBoard of DirectorsPurchase55.0K$0.83$45.9K
Jul 24, 2019Fuad El-HibriBoard of DirectorsPurchase10.0K$0.90$9.0K
Jul 23, 2019Fuad El-HibriBoard of DirectorsPurchase30.0K$0.89$26.6K
Jul 19, 2019Fuad El-HibriBoard of DirectorsPurchase26.5K$0.90$23.7K
Jul 18, 2019Fuad El-HibriBoard of DirectorsPurchase14.4K$0.87$12.6K
Jul 18, 2019Fuad El-HibriBoard of DirectorsPurchase19.1K$0.87$16.7K
Jul 16, 2019Fuad El-HibriBoard of DirectorsPurchase11.4K$0.85$9.7K
Jul 12, 2019Fuad El-HibriBoard of DirectorsPurchase14.7K$0.85$12.5K
Jul 11, 2019Fuad El-HibriDirectorPurchase18.9K$0.85$16.1K
Jun 25, 2019Daniel Abdun-NabiBoard of DirectorsPurchase16.7K$0.90$15.0K
Jun 14, 2019Marvin L WhitePresident and CEOPurchase50.0K$0.88$44.0K
Jun 11, 2019Barbara Lopez KunzBoard of DirectorsPurchase10.0K$0.85$8.5K
Jun 7, 2019Zsolt HarsanyiBoard of DirectorsPurchase50.0K$0.78$39.0K
Jun 7, 2019Randy Joe MadduxSenior VP, OperationsPurchase20.0K$0.73$14.6K
May 21, 2019Grady Grant IIIBoard of DirectorsPurchase10.0K$0.80$8.0K
May 20, 2019Marvin L WhitePresident and CEOPurchase30.0K$0.81$24.3K
May 15, 2019Marvin L WhitePresident and CEOPurchase10.0K$0.78$7.8K
Dec 7, 2018Randy Joe MadduxSVP OperationsPurchase5.0K$2.37$11.8K

Showing the 25 most recent of 26 Form 4 filings for Aptevo Therapeutics Inc..

Most active APVO insiders

  • Fuad El-Hibri10 filings
  • Marvin L White4 filings
  • Kevin C Tang3 filings
  • Randy Joe Maddux3 filings
  • Grady Grant III2 filings

Ask anything about APVO insider activity

Use Trabud's AI agent to query Aptevo Therapeutics Inc.'s Form 4 history in plain English — "Show me APVO CEO purchases this year" or compare it against any other ticker.

Open the AI agent

APVO insider trading FAQ

Are Aptevo Therapeutics Inc. insiders buying or selling?

Across 26 SEC Form 4 filings, Aptevo Therapeutics Inc. (APVO) insiders reported 24 open-market purchases totaling $25.3M and 2 sales totaling $16.9M. That is a net buying position of $8.5M.

How many insiders trade APVO stock?

9 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Aptevo Therapeutics Inc.. The most recent filing was accepted on Nov 12, 2025.

Where does Trabud get APVO insider trading data?

All APVO insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content